Albuquerque Neuroscience

Name

Albuquerque Neuroscience

Legal name

Albuquerque Neuroscience

Website

https://albneuro.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)

Keywords

• Clinical trial site
• Neuroscience research
• Patient recruitment
• CNS clinical trials
• Clinical research services

Headquarters

HQ city

Albuquerque

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: Provides site-based clinical trial services to pharmaceutical sponsors and CROs, earning fees for patient enrollment and trial conduct. Revenue is derived from per-patient enrollment fees and trial execution services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Albuquerque Neuroscience operates as a clinical trial site within the IMA Clinical Research network, conducting site-based, hybrid, and fully decentralized clinical trials focused on diseases of the central nervous system (CNS) and general medical conditions. The site recruits and enrolls patients on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs), with current emphasis on memory loss trials (adults 55+) and depression trials. It leverages the IMA network's shared patient database (400K+) and standardized operational processes to deliver high-quality trial data.

Differentiator

Problem solved

Functional benefit

Products and services

• Site-Based Clinical Trial Services
• Memory Loss Clinical Trials
• Depression Clinical Trials

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• IMA Clinical ResearchcoreStrategic or Co-development PartnerAlbuquerque Neuroscience operates as a location/site under the IMA Clinical Research network. As part of this network, it benefits from shared patient databases, standardized operational processes, and collective resources for clinical trial services.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Medpace: Mid-to-large global CRO with embedded site management capabilities and CNS therapeutic expertise; a broader incumbent that competes for the same sponsor trial placements.
• Syneos Health: Global biopharma solutions organization combining CRO and site network services, with CNS therapeutic capability — competes at the sponsor contract layer for CNS trials.
• Accelerated Enrollment Solutions (PPD / Thermo Fisher): Large dedicated clinical trial site network inside a global CRO, offering similar multi-therapeutic site services and patient recruitment capabilities — a broader incumbent competitor.
• IQVIA: Largest global CRO with extensive site network and patient recruitment infrastructure including CNS — overlaps with Albuquerque Neuroscience on sponsor contracts and trial placement decisions.

Direct peers

• Flourish Research: Multi-site U.S. clinical research organization focused on Phase II–IV trials with therapeutic breadth overlapping CNS, cardiology, and general medicine — comparable site-based model.
• Clinipace Worldwide: Mid-sized CRO with therapeutic focus including oncology and CNS, offering site management and patient recruitment — comparable business model with overlap on CNS sponsors.
• Benchmark Research: U.S. clinical research site network conducting Phase II–IV trials across multiple therapeutic areas including CNS, with comparable site-based operations and sponsor/CRO contracting.
• Meridian Clinical Research: Multi-therapeutic dedicated clinical trial site network in the U.S. operating a similar site-based, sponsor-facing model with direct patient recruitment — a like-for-like SMO comparable to IMA's network.
• IMA Clinical Research: Direct parent organization operating the broader 150+ site network that Albuquerque Neuroscience belongs to. Most directly comparable entity because it sets the operational model, patient database, and sponsor relationships the site depends on.

Emerging players

• Care Access Research: Decentralized clinical trial operator with site and mobile research capabilities; overlapping GTM motion through flexible/decentralized trial models that compete for sponsor attention.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/albuquerque-neuroscience-inc
• Instagraminstagram.com/imaclinicalresearch
• Facebookfacebook.com/AlbuquerqueNeuroscienceInc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Albuquerque Neuroscience